Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Fallopian Tube Neoplasms × niraparib × Clear all

Phase

Status

Sponsor Class

OTHER 10 INDUSTRY 7 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Fallopian Tube Neoplasms 1

Interventions

taxane 2 Surgical Procedures, Operative 2 Poly(ADP-ribose) Polymerase Inhibitors 2 Neoadjuvant Therapy 2 Carboplatin 2 Bevacizumab 2 olaparib 1 niraparib 1 cediranib 1 Platinum 1 Paclitaxel 1 Maintenance 1 Etoposide 1 Drug Therapy 1 Diagnostic Imaging 1 CP protocol 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03983226 2022-03-18

Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

Shanghai Gynecologic Oncology Group

Phase 2 Recruiting

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡